Department of General Pediatrics and Neonatology, University Childreńs Hospital, Duesseldorf, Germany.
PLoS One. 2012;7(9):e45429. doi: 10.1371/journal.pone.0045429. Epub 2012 Sep 14.
Very long-chain acyl-CoA dehydrogenase (VLCAD)-deficiency is the most common long-chain fatty acid oxidation disorder presenting with heterogeneous phenotypes. Similar to many patients with VLCADD, VLCAD-deficient mice (VLCAD(-/-)) remain asymptomatic over a long period of time. In order to identify the involved compensatory mechanisms, wild-type and VLCAD(-/-) mice were fed one year either with a normal diet or with a diet in which medium-chain triglycerides (MCT) replaced long-chain triglycerides, as approved intervention in VLCADD. The expression of the mitochondrial long-chain acyl-CoA dehydrogenase (LCAD) and medium-chain acyl-CoA dehydrogenase (MCAD) was quantified at mRNA and protein level in heart, liver and skeletal muscle. The oxidation capacity of the different tissues was measured by LC-MS/MS using acyl-CoA substrates with a chain length of 8 to 20 carbons. Moreover, in white skeletal muscle the role of glycolysis and concomitant muscle fibre adaptation was investigated. In one year old VLCAD(-/-) mice MCAD and LCAD play an important role in order to compensate deficiency of VLCAD especially in the heart and in the liver. However, the white gastrocnemius muscle develops alternative compensatory mechanism based on a different substrate selection and increased glucose oxidation. Finally, the application of an MCT diet over one year has no effects on LCAD or MCAD expression. MCT results in the VLCAD(-/-) mice only in a very modest improvement of medium-chain acyl-CoA oxidation capacity restricted to cardiac tissue. In conclusion, VLCAD(-/-) mice develop tissue-specific strategies to compensate deficiency of VLCAD either by induction of other mitochondrial acyl-CoA dehydrogenases or by enhancement of glucose oxidation. In the muscle, there is evidence of a muscle fibre type adaptation with a predominance of glycolytic muscle fibres. Dietary modification as represented by an MCT-diet does not improve these strategies long-term.
长链酰基辅酶 A 脱氢酶(VLCAD)缺乏症是最常见的长链脂肪酸氧化障碍,表现出异质性表型。与许多 VLCADD 患者类似,长链酰基辅酶 A 脱氢酶缺乏症(VLCAD(-/-))的小鼠在很长一段时间内无症状。为了确定涉及的代偿机制,野生型和 VLCAD(-/-)小鼠分别用正常饮食或用中链甘油三酯(MCT)代替长链甘油三酯的饮食喂养一年,这是 VLCADD 的一种批准干预措施。在心脏、肝脏和骨骼肌中,通过实时 PCR 定量测定线粒体长链酰基辅酶 A 脱氢酶(LCAD)和中链酰基辅酶 A 脱氢酶(MCAD)的 mRNA 表达,并通过 LC-MS/MS 用 8 至 20 个碳原子长的酰基辅酶 A 底物测量不同组织的氧化能力。此外,在白色骨骼肌中,还研究了糖酵解和伴随的肌肉纤维适应的作用。在一岁的 VLCAD(-/-)小鼠中,MCAD 和 LCAD 发挥着重要作用,以弥补 VLCAD 的缺乏,尤其是在心脏和肝脏中。然而,白色比目鱼肌则基于不同的底物选择和增加的葡萄糖氧化来发展替代的代偿机制。最后,一年的 MCT 饮食应用对 LCAD 或 MCAD 表达没有影响。MCT 仅导致 VLCAD(-/-)小鼠的中链酰基辅酶 A 氧化能力略有改善,仅限于心脏组织。总之,VLCAD(-/-)小鼠通过诱导其他线粒体酰基辅酶 A 脱氢酶或增强葡萄糖氧化来发展组织特异性策略来补偿 VLCAD 的缺乏。在肌肉中,有证据表明存在纤维类型适应,以糖酵解肌肉纤维为主。饮食干预(如 MCT 饮食)并不能长期改善这些策略。